CMND (CMND) Stock Price & Analysis
CMND (CMND) fell 10.55% to USD 3.39 as of June 10, 2026 at 02:19 UTC, according to Nexqual real-time market data.
CMND last closed at USD 3.79; the session ranged USD 3.25–3.6 on volume of 242,065 shares. Market capitalization is $3.45M, with a 52-week range of USD 2.1–524 (NCM). Source: Nexqual, June 10, 2026 at 02:19 UTC.
Key Statistics (as of June 10, 2026 at 02:19 UTC)
| Price | USD 3.39 |
|---|---|
| Change | ▼ 10.55% (down) |
| Previous Close | USD 3.79 |
| Open | USD 3.29 |
| Day Range | USD 3.25 – 3.6 |
| 52-Week Range | USD 2.1 – 524 |
| Volume | 242,065 shares |
| Market Cap | $3.45M |
| Exchange | NCM |
Technical Analysis (CMND)
Nexqual's technical model rates CMND "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:19 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 38.55 (neutral) |
| vs SMA50 | Below (USD 6.65) |
| MACD | -0.84 (negative) |
Analyst Ratings (CMND)
Wall Street analysts rate CMND "None", per Nexqual as of June 10, 2026 at 02:19 UTC.
| Consensus Rating | None |
|---|
Earnings (CMND)
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Financials & Fundamentals (CMND)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -119.72% |
| Debt / Equity | 0.1 |
| Current Ratio | 3.79 |
| Total Cash | $10.35M |
| Total Debt | $7,977 |
| Free Cash Flow | $-5.39M |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Financial Health Score (CMND)
Nexqual rates CMND's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:19 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Strong — $10M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -120%, ROA -55.2% |
Ownership (CMND)
| Insider Ownership | +0.14% |
|---|---|
| Institutional Ownership | +0.44% |
| Shares Outstanding | 1.02M |
| Float | 208,599 |
| Short % of Float | +3.98% |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Leadership (CMND)
CMND is led by Adi Zuloff-Shani (age 58), Chief Executive Officer, per Nexqual as of June 10, 2026 at 02:19 UTC.
| Chief Executive Officer | Adi Zuloff-Shani (age 58) |
|---|---|
| Chief Financial Officer | Alan Mark Rootenberg B.Com., B.Comm, C.A. (age 73) |
| Vice President of Business Development | Mark Haden M.S.W. (age 72) |
Major Backers & Investors (CMND)
Notable institutional backers of CMND include Xtx Topco Ltd, HRT Financial LP, according to Nexqual as of June 10, 2026 at 02:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Xtx Topco Ltd | 0.21% |
| HRT Financial LP | 0.16% |
Source: Nexqual, June 10, 2026 at 02:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 9.31 | ▼ 18.62% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.94 | ▼ 1.02% |
| BDRX | Biodexa Pharmaceuticals plc | USD 3.1 | ▼ 7.74% |
| FRGT | Freight Technologies, Inc. | USD 4.5 | ▲ 6.64% |
| NEXR | Nexera Technologies Ltd | USD 0.8 | ▼ 33.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:19 UTC. This page is informational and not investment advice.